Mass General Brigham: Study Finds Ketamine is at Least as Effective as ECT for Treating Major Depression
May 25, 2023
May 25, 2023
BOSTON, Massachusetts, May 25 (TNSjou) -- Mass General Brigham issued the following news release:
A new study led by investigators from Mass General Brigham has found that subanesthetic intravenous ketamine was effective and not inferior to electroconvulsive therapy (ECT) for the treatment of non-psychotic, treatment-resistant depression. Their results are published in the New England Journal of Medicine.
"ECT has been the gold standard for treating severe depressi . . .
A new study led by investigators from Mass General Brigham has found that subanesthetic intravenous ketamine was effective and not inferior to electroconvulsive therapy (ECT) for the treatment of non-psychotic, treatment-resistant depression. Their results are published in the New England Journal of Medicine.
"ECT has been the gold standard for treating severe depressi . . .